期刊文献+

indocyanine green-based fluorescence imaging in visceral and hepatobiliary and pancreatic surgery:State of the art and future directions 被引量:26

Indocyanine green-based fluorescence imaging in visceral and hepatobiliary and pancreatic surgery: State of the art and future directions
下载PDF
导出
摘要 In recent years, the use of fluorescence-guided surgery(FGS) to treat benign and malignant visceral, hepatobiliary and pancreatic neoplasms has significantly increased. FGS relies on the fluorescence signal emitted by injected substances(fluorophores) after being illuminated by ad hoc laser sources to help guide the surgical procedure and provide the surgeon with real-time visualization of the fluorescent structures of interest that would be otherwise invisible. This review surveys and discusses the most common and emerging clinical applications of indocyanine green(ICG)-based fluorescence in visceral, hepatobiliary and pancreatic surgery. The analysis, findings, and discussion presented here rely on the authors' significant experience with this technique in their medical institutions, an up-to-date review of the most relevant articles published on this topic between 2014 and 2018, and lengthy discussions with key opinion leaders in the field during recent conferences and congresses. For each application, the benefits and limitations of this technique, as well as applicable future directions, are described. The imaging of fluorescence emitted by ICG is a simple, fast,relatively inexpensive, and harmless tool with numerous different applications in surgery for both neoplasms and benign pathologies of the visceral and hepatobiliary systems. The ever-increasing availability of visual systems that can utilize this tool will transform some of these applications into the standard of care in the near future. Further studies are needed to evaluate the strengths and weaknesses of each application of ICG-based fluorescence imaging in abdominal surgery. In recent years, the use of fluorescence-guided surgery(FGS) to treat benign and malignant visceral, hepatobiliary and pancreatic neoplasms has significantly increased. FGS relies on the fluorescence signal emitted by injected substances(fluorophores) after being illuminated by ad hoc laser sources to help guide the surgical procedure and provide the surgeon with real-time visualization of the fluorescent structures of interest that would be otherwise invisible. This review surveys and discusses the most common and emerging clinical applications of indocyanine green(ICG)-based fluorescence in visceral, hepatobiliary and pancreatic surgery. The analysis, findings, and discussion presented here rely on the authors' significant experience with this technique in their medical institutions, an up-to-date review of the most relevant articles published on this topic between 2014 and 2018, and lengthy discussions with key opinion leaders in the field during recent conferences and congresses. For each application, the benefits and limitations of this technique, as well as applicable future directions, are described. The imaging of fluorescence emitted by ICG is a simple, fast,relatively inexpensive, and harmless tool with numerous different applications in surgery for both neoplasms and benign pathologies of the visceral and hepatobiliary systems. The ever-increasing availability of visual systems that can utilize this tool will transform some of these applications into the standard of care in the near future. Further studies are needed to evaluate the strengths and weaknesses of each application of ICG-based fluorescence imaging in abdominal surgery.
出处 《World Journal of Gastroenterology》 SCIE CAS 2018年第27期2921-2930,共10页 世界胃肠病学杂志(英文版)
关键词 indocyanine green FLUORESCENCE IMAGING gastrointestinal SURGERY liver SURGERY BILIARY SURGERY pancreatic SURGERY VISCERAL perfusion BILIARY anatomy peritoneal CARCINOMATOSIS Indocyanine green Fluorescence imaging Gastrointestinal surgery Liver surgery Biliary surgery Pancreatic surgery visceral perfusion Biliary anatomy Peritoneal carcinomatosis
  • 相关文献

参考文献1

二级参考文献35

  • 1Flum DR, Dellinger EP, Cheadle A, Chan L, Koepsell T.Intraoperative cholangiography and risk of common bile duct injuryduring cholecystectomy. JAMA 2003; 289: 1639-1644 [PMID:12672731 DOI: 10.1001/jama.289.13.1639].
  • 2Ministry of Health, Labour and Welfare of Japan. Proceedings ofCentral Social Insurance Medical Council, 2008. Accessed 26 June2009. Available from: URL: http://www.mhlw.go.jp/shingi/2009/05/s0514-6.html.
  • 3Z'graggen K, Wehrli H, Metzger A, Buehler M, Frei E, Klaiber C.Complications of laparoscopic cholecystectomy in Switzerland. Aprospective 3-year study of 10,174 patients. Swiss Association ofLaparoscopic and Thoracoscopic Surgery. Surg Endosc 1998; 12:1303-1310 [PMID: 9788852 DOI: 10.1007/s004649900846].
  • 4Fletcher DR, Hobbs MS, Tan P, Valinsky LJ, Hockey RL,Pikora TJ, Knuiman MW, Sheiner HJ, Edis A. Complications ofcholecystectomy: risks of the laparoscopic approach and protectiveeffects of operative cholangiography: a population-based study. AnnSurg 1999; 229: 449-457 [PMID: 10203075 DOI: 10.1097/00000658-199904000-00001].
  • 5Nuzzo G, Giuliante F, Giovannini I, Ardito F, D'Acapito F, VelloneM, Murazio M, Capelli G. Bile duct injury during laparoscopiccholecystectomy: results of an Italian national survey on 56 591cholecystectomies. Arch Surg 2005; 140: 986-992 [PMID: 16230550DOI: 10.1001/archsurg.140.10.986].
  • 6Waage A, Nilsson M. Iatrogenic bile duct injury: a populationbasedstudy of 152 776 cholecystectomies in the Swedish InpatientRegistry. Arch Surg 2006; 141: 1207-1213 [PMID: 17178963 DOI:10.1001/archsurg.141.12.1207].
  • 7Japan Society for Endoscopic Surgery. The 9th QuestionnaireSurvey. Accessed 26 June 2009. Available from: URL: http://www.med.oita-u.ac.jp/surgery1/JSES09/index2.html.
  • 8Flum DR, Cheadle A, Prela C, Dellinger EP, Chan L. Bileduct injury during cholecystectomy and survival in medicarebeneficiaries. JAMA 2003; 290: 2168-2173 [PMID: 14570952 DOI:10.1001/jama.290.16.2168].
  • 9Way LW, Stewart L, Gantert W, Liu K, Lee CM, Whang K, HunterJG. Causes and prevention of laparoscopic bile duct injuries: analysisof 252 cases from a human factors and cognitive psychologyperspective. Ann Surg 2003; 237: 460-469 [PMID: 12677139 DOI:10.1097/01.SLA.0000060680.92690.E9].
  • 10Connor S, Garden OJ. Bile duct injury in the era of laparoscopiccholecystectomy. Br J Surg 2006; 93: 158-168 [PMID: 16432812DOI: 10.1002/bjs.5266].

共引文献24

同被引文献131

引证文献26

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部